First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors

Clinical trial NCT03616574 · COMPLETED

Trial details

NCT number: NCT03616574
Sponsor: Holy Stone Healthcare Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Advanced or Metastatic Colorectal Cancer (mCRC)

Start date: 2019-04-09
Primary completion: 2022-02-08
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.